Latest blog articles

Unlike other sectors, improvements in Genetic technology raise issues of morality. The new human gene editing technology CRISPR/CAS9 has raised many such concerns. Can the current patent system deal with these concerns or should morality be dealt with by the inventors themselves?

‘CISG Conference’ where experts on the international sale of goods came together to review the Vienna Convention in the light of similar structures such as its latest contender, the Common European Sales Law, or the UCC.

Mark Kawakami: "From a rather ignorant American’s perspective, the cost of learning, debating, and trying to apply the continuously changing (or “harmonizing”) European law is so cumbersome that perhaps it is doing more harm than good to the European legal framework".